rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Kestra Medical Technologies, Ltd.

KMTS · Nasdaq

Health CareMedical DevicesJust started moving

KMTS stood above a rising 150-day average in 22 of the last 50 weekly readings, including each of the last 2 weeks. It is 25.9% above that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−7 points in four weeks); Health Care: 26% (−10 points in four weeks).

Statistics

Rotation
Just started moving
Weeks in an uptrend
2 in a row
Industry in uptrend
27% -7 in 4 wk
Insider buys, 12 months
$400K
Insider sales, 12 months
$17.2M
Officials’ trades on record
0
Institutions holding
106 (+8)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 50 weeks.

20 Apr – 19 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$7.2M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months1
Sale orders, 12 months36
Buyers · sellers1 · 11
WhoDidSharesTraded
Raymond W. CohenDirectorsold3,330at $29.2830 Sep 2026filed 1 Oct 2026
Elizabeth KwoDirectorsold4,010at $24.2621 Sep 2026filed 23 Sep 2026
Jeffrey Lawrence SchwartzDirector, 10% ownersold3,890at $25.188 Sep 2026filed 10 Sep 2026
Mary Kay LadoneDirectorsold3,908at $25.208 Sep 2026filed 10 Sep 2026
Kevin C. ReillyDirectorsold2,932at $25.138 Sep 2026filed 10 Sep 2026
Conor HanleyDirectorsold5,694at $25.258 Sep 2026filed 10 Sep 2026
Brian Daniel WebsterDirector, Officersold15,000at $27.4817 Aug 2026filed 18 Aug 2026
Vaseem MahboobChief Financial Officersold25,787at $25.877 Aug 2026filed 11 Aug 2026
Vaseem MahboobChief Financial Officersold500at $26.337 Aug 2026filed 11 Aug 2026
Brian Daniel WebsterDirector, Officersold48,625at $24.474 Aug 2026filed 6 Aug 2026
Brian Daniel WebsterDirector, Officersold2,833at $25.164 Aug 2026filed 6 Aug 2026
Brian Daniel WebsterDirector, Officersold442at $25.984 Aug 2026filed 6 Aug 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders106+8 on the quarter
New · exited19 · 10
Reported value$1.4B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
Bain Capital Investors LLCunchanged · filed 14 Aug 202625,172,338$640.4M00.0%
FMR LLCreduced · filed 13 Aug 20265,523,647$140.5M-197,407−3.5%
ANDERA PARTNERSadded · filed 22 Jul 20262,728,679$69.4M+33,487+1.2%
Yu Fanunchanged · filed 14 Aug 20262,282,519$58.1M00.0%
BROWN ADVISORY INCadded · filed 14 Aug 20261,909,056$48.6M+185,326+10.8%
BlackRock, Inc.added · filed 7 Aug 20261,865,496$47.5M+176,249+10.4%
ALLIANCEBERNSTEIN L.P.added · filed 14 Aug 20261,477,992$29.5M+157,618+11.9%
EVENTIDE ASSET MANAGEMENT, LLCadded · filed 14 Aug 20261,446,742$36.8M+878+0.1%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20261,175,525$29.9M-37,168−3.1%
FRANKLIN RESOURCES INCreduced · filed 13 Aug 20261,123,622$28.6M-119,583−9.6%
31 Mar 2025 – 30 Jun 2026
5881104Mar 25Jun 25Dec 25Mar 26Jun 26

Everyone who traded it

Raymond W. Cohen Company insiderDirector · last 30 Sep 20262 · 1
Elizabeth Kwo Company insiderDirector · last 21 Sep 20260 · 1
Conor Hanley Company insiderDirector · last 9 Sep 20260 · 1
Jeffrey Lawrence Schwartz Company insiderDirector, 10% owner · last 9 Sep 20260 · 1
Kevin C. Reilly Company insiderDirector · last 9 Sep 20260 · 1
Mary Kay Ladone Company insiderDirector · last 9 Sep 20260 · 1
Brian Daniel Webster Company insiderDirector, Officer · last 17 Aug 20260 · 13
Vaseem Mahboob Company insiderChief Financial Officer · last 7 Aug 20260 · 5
Alfred J. Ford Jr. Company insiderChief Commercial Officer · last 4 Aug 20261 · 4
Traci S. Umberger Company insiderDirector, Officer · last 4 Aug 20261 · 5
Timothy P. Moran Company insiderChief Business Officer · last 3 Aug 20260 · 3

Same industry

RCEL Avita MedicalLeading+100%
HAE HaemoneticsLeading+48%
ATRC AtriCureLeading+47%
HTFL HeartflowLeading+47%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2026 · to 30 Apr 202651.4%
Operating profit marginFY 2026 · to 30 Apr 2026-142%
Free cash flow marginFY 2026 · to 30 Apr 2026-123%
Return on capital employedFY 2026 · to 30 Apr 2026-43.7%
Debt to equityFY 2026 · to 30 Apr 20260.16×
Research spendFY 2026 · to 30 Apr 202620.5%
Share count trendFY 2026 · to 9 Jul 20260.4%
Cash and equivalentsFY 2026 · to 30 Apr 2026$99.7M
Free cash flowFY 2026 · to 30 Apr 2026−$116.6M

Analyst forecasts

No analyst forecasts yet.